Graham N - Search Results

1

Safety profile and tolerability of amprenavir in patients enrolled in an early access program.

Scott T, Garris C, Rogers M, Graham N, Garrett L, Pedneault L. Scott T, et al. Among authors: graham n. Clin Ther. 2001 Feb;23(2):252-9. doi: 10.1016/s0149-2918(01)80007-2. Clin Ther. 2001. PMID: 11293558 Clinical Trial.

2

Studies of antiretroviral therapy in the Multicenter AIDS Cohort Study.

Graham NM. Graham NM. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17 Suppl 1:S9-12. doi: 10.1097/00042560-199801001-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9586644 Clinical Trial.

3

Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study.

Detels R, Muñoz A, Peng Y, Graham N, Mellors J, Phair J. Detels R, et al. Among authors: graham n. Antivir Ther. 1997 Jan;2(1):21-9. Antivir Ther. 1997. PMID: 11322263 Clinical Trial.

4

Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort.

Becker SL, Raffanti SR, Hansen NI, Fusco JS, Fusco GP, Slatko GH, Igboko EF, Graham NM; Collaborations in HIV Outcomes Research--US (CHORUS) Program Team. Becker SL, et al. Among authors: graham nm. J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):72-81. doi: 10.1097/00126334-200101010-00011. J Acquir Immune Defic Syndr. 2001. PMID: 11176271 Clinical Trial.

5

Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS. Multicenter AIDS Cohort Study.

Lyles RH, Tang AM, Smit E, Mellors JW, Margolick JB, Visscher BR, Phair JP, Graham NM. Lyles RH, et al. Among authors: graham nm. J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):386-94. doi: 10.1097/00126334-199912010-00010. J Acquir Immune Defic Syndr. 1999. PMID: 10634201 Clinical Trial.

6

Session B: The role of patient databases in assessing antiretroviral treatment.

Graham N. Graham N. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17 Suppl 1:S46-7. doi: 10.1097/00042560-199801001-00014. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9586653 No abstract available.

7

Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS.

Graham NM, Sorensen D, Odaka N, Brookmeyer R, Chan D, Willett WC, Morris JS, Saah AJ. Graham NM, et al. J Acquir Immune Defic Syndr (1988). 1991;4(10):976-80. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1890606

8

Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).

Solomon L, Stein M, Flynn C, Schuman P, Schoenbaum E, Moore J, Holmberg S, Graham NM. Solomon L, et al. Among authors: graham nm. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):253-61. doi: 10.1097/00042560-199803010-00011. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9495226

9

The effects on survival of early treatment of human immunodeficiency virus infection.

Graham NM, Zeger SL, Park LP, Vermund SH, Detels R, Rinaldo CR, Phair JP. Graham NM, et al. N Engl J Med. 1992 Apr 16;326(16):1037-42. doi: 10.1056/NEJM199204163261601. N Engl J Med. 1992. PMID: 1347907 Free article. Clinical Trial.

10

Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.

Graham NM, Zeger SL, Kuo V, Jacobson LP, Vermund SH, Phair JP, Detels R, Rinaldo CR, Saah AJ. Graham NM, et al. J Acquir Immune Defic Syndr (1988). 1991;4(3):267-76. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1671411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,127 results

Search Page

Filters